Patient safety – at the core of our business

Patient safety – at the core of our business Pharmacist Arvid Cronlund is more than merited to head the Drug Safety department at Immedica Pharma. He has over 20 years of experience working with patient safety. Patient safety is paramount for Immedica, since all medical products can cause side-effects. Our challenge – minimizing the risk […]

How to ensure medical supply in a global crisis

How to ensure medical supply in a global crisis Orphan drugs are vital, sometimes life-saving. How can you ensure that medicine reaches the patients during a crisis? How do you manage reduced access to essential ingredients, closed transport routes, and other unexpected events?  Mikael Näslund, Head of Supply at Immedica Pharma, shares his insights. Mikael […]

Do you want a career in rare diseases?

Do you want a career in rare diseases? Check if you have the capabilities needed. Immedica Pharma provides pharmaceuticals to patients with rare diseases and their caregivers. Working with rare diseases and orphan drugs is extremely gratifying as treatment is of utter importance for the patients’ health and life quality. Gunilla Mickelsson, Head of Northern […]

Successful tech transfer in pharma is key

The Immedica way of managing manufacturing Where are Immedica’s products manufactured? Immedica does not perform manufacturing internally, meaning that we do not own any factories or labs. Rather, we work closely with a network of Contract Manufacturing Organizations (CMOs) to manufacture our products. This brings many benefits for us since we can choose CMO based […]

We can do better for rare diseases in the Nordics

We can do better for rare diseases in the Nordics Although these diseases are called rare, about 1 million people have a rare disease diagnosis in the Nordic countries. Many of the patients, or their parents, experience a struggle to get the diagnosis in time, be fully understood by the health care providers, and to […]

Immedica & China

China’s pharmaceutical market has constantly been growing in the last years, and it is now the second-largest market in the world. Calculations show that it will be worth $161.8 billion by 2023. Even though it has slowed down a bit, a reason for the fast growth is that the Chinese central government realized that changes […]

Three factors to consider when working with rare diseases

Three factors to consider when working with rare diseases

Three factors to consider when working with rare diseases Roland Gerke, Immedica Pharma in Germany, Austria, and Switzerland has over 20 years of experience serving patients with rare diseases. Over time he has accumulated extensive experience and knowledge. Now, he shares three key factors to be successful in the business. The search for the “needle in […]

Immedica shares know-how and expertise with individuals with Urea Cycle Disorders

Immedica shares know-how and expertise with individuals with Urea Cycle Disorders Knowing that something is not right is hard. Sometimes it takes a long time before a patient gets the correct diagnosis. Being diagnosed with a rare, life-changing, and severe disease, like Urea Cycle Disorders (UCDs), might come as a shock. In that turmoil, it […]

Doing business in Middle East and North Africa

Doing business in Middle East and North Africa 5 tips for a successful pharma business in the Middle East and North Africa (MENA). In recent years, the region has strived to diversify its oil-based economies. This broadening of horizons has created an opportunity for global investors to venture further into the area. But it can […]